Keywords: aFVII; activated FVII; AHA; acquired hemophilia A; anti-hFVIII; anti-human FVIII; aPCC; activated prothrombin complex concentrate; aPTT; activated partial thromboplastin time; AT; antithrombin; AUC; area under the curve; BPA; bypassing agent; BU; Bethesda
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: PS; phosphatidylserine; NVAF; non-valvular atrial fibrillation; MPs; microparticles; PCA; procoagulant activity; RDW; red cell distribution width; PMPs; platelet-derived MPs; EMPs; endothelial-derived MPs; LMPs; leukocyte-derived MPs; WBC; white blood cel
Keywords: ACT; activated clotting time; APTT; activated partial thromboplastin time; ATAD; acute thoracic aortic dissection; AT-III; antithrombin III; COPD; chronic obstructive pulmonary disease; CPB; cardiopulmonary bypass; CRP; C-reactive protein; CTAD; chronic t
Keywords: AHA/ACC; American Heart Association/American College of Cardiology; APTT; active partial thromboplastin time; AR chip; chip for mixed white thrombus analysis; ATIII; antithrombin III; AUC; area under the flow pressure curve; DAP; diastolic arterial blood
Keywords: AII; angiotensin II; ACT; activated clotting time; aPTT; activated partial-thromboplastin time; ARDS; acute respiratory distress syndrome; BARC; Bleeding Academic Research Consortium; dTT; dilute thrombin time; ECT; ecarin clotting time; EHR; electronic h
Keywords: aPTT; activated partial thromboplastin time; BAL; broncho-alveolar lavage; BSA; bovine serum albumin; CRP; C-reactive protein; DAB; 3,3â²-diaminobenzidine; ENPRA; engineered nanoparticle risk assessment; GSH; reduced glutathione; GSSG; oxidized glutathio
Keywords: PBS; phosphate-buffered saline; r; Clot time; K; Clot formation time; α Angle; Rate of clot formation; CI; Coagulation Index; MA; Maximum strength; TEG; Thrombelastography; ATC; acute traumatic coagulopathy; TIC; trauma induced coagulopathy; PT; prothrom
Keywords: AIS; Abbreviated Injury Scale; AKI; acute kidney injury; aPTT; activated partial thromboplastin time; CC16; Clara Cell Protein 16; DAMP; danger-associated molecule pattern; GCS; Glasgow Coma Scale; HS; hemorrhagic shock; I-FABP; liver â/intestinal-type
Keywords: Honokiol microemulsion; Acute toxicity; Subchronic toxicity; Genotoxicity; Beagle dog; 2-AF; 2-aminofluorene; 4-NQO; 4-Nitroquinoline-N-oxide; A/G; albumin/globulin; ALB; albumin; ALP; alkaline phosphatase; ALT; alanine aminotransferase; ANOVA; analysis o
Keywords: Amax; maximal thrombin concentration; APTT; activated partial thromboplastin time; AT; antithrombin III; CVerror; relative random error of measurement; CVii; inter-individual coefficient of variability; CVtotal; total coefficient of variation; ETP; endoge
Keywords: OAC; Oral anticoagulant; VKA; Vitamin K antagonist; DOAC; Direct oral anticoagulant; PCC; Prothrombin complex concentrate; 4F-PCC; Four factor PCC; 3F-PCC; Three factor PCC; aPCC; Activated PCC; FFP; Fresh frozen plasma; AF; Atrial fibrillation; TE; Throm
Keywords: Tracheostomy; Weaning; Mechanical ventilation; Cardiac surgery; APTT; Activated partial thromboplatin time; ARDS; Acute respiratory distress syndrome; CABG; Coronary Artery Bypass Grafting; COPD; Chronic Obstructive Pulmonary disease; CRRT; Continuous Ren
Keywords: critically ill; heparin; heparin-induced thrombocytopenia; thrombocytopenia; thrombosis; APTT; activated partial thromboplastin time; DIC; disseminated intravascular coagulation; DOAC; direct oral anticoagulant; ECMO; extracorporeal membrane oxygenation;
Keywords: aPTT; activated partial thrombosplatin time; BMI; body mass index; FMD; flow-mediated dilation; HDL-c; high density lipoprotein cholesterol; LDL-c; low-density lipoprotein cholesterol; MMP-9; matrix metalloproteinase-9; OSI; oscillatory shear index; OSS;
Keywords: PT; prothrombin time; PT-INR; prothrombin time-international normalized ratio; APTT; activated partial thromboplastin time; CT; computed tomography; IVR; interventional radiography; LCA; left colic artery; SRA; superior rectal artery; DOAC; direct oral an
Keywords: AF; atrial fibrillation; ACT; activated clotting time; aPTT; activated partial thromboplastin time; b.i.d.; twice daily; dTT; diluted thrombin time; ECT; ecarin clotting time; FFP; fresh frozen plasma; FXa; factor X activated; INR; International Normalize
Keywords: SC; Stable Cirrhosis; AD; Acute Decompensated Chronic Liver Disease; ACLF; Acute on Chronic Liver Failure; HC; Healthy Control; TM; Thrombomodulin; ETP; Endogenous Thrombin Potential; ICU; Intensive Care Unit; INR; International Normalized Ratio; PT; Pro-
Keywords: Acquired coagulopathies; Acquired hemophilia A; Hemostatic screening; Neurosurgical procedure; 3D; Three-dimensional; AHA; Acquired hemophilia A; APCC; Activated prothrombin complex concentrate; aPTT; Activated partial thromboplastin time; CT; Computed to
Keywords: ALB; total albumin; ALP; alkaline phosphatase; ALT; alanine aminotransferase; APTT; activated partial thromboplastin time; AST; aspartate aminotransferase; BIL; bilirubin; BLO; occult blood; BUN; blood urea nitrogen; CHO; cholesterol; CK; creatine kinase;
Keywords: ADP; adenosine diphosphate; ANOVA; one-way analysis of variance; APTT; activated partial thromboplastin time; ASP; aspirin; CLO; clopidogrel; CVD; cardiovascular diseases; eNOS; endothelial nitric oxide synthase; ET; endothelin; FIB; fibrinogen concentrat
Keywords: aPTT; activated partial thromboplastin time; α2MG; α2 macroglobulin; CAMR; chronic antibody-mediated rejection; DFPP; double-filtration plasmapheresis; DSA; donor-specific allo-antibody; ETP; endogenous thrombin potential; MFI; mean fluorescence intensi
Keywords: CS; chitosan; GAG; glycosaminoglycan; DDA; degree of deacetylation; ECM; extracellular matrix; FFSA; 5-formyl-2-furansulfonic acid; BZ1S; 2-formylbenzene sulfonic acid; BZ2S; 4-formyl-1,3-benzenedisulfonic acid; APTT; activated partial thromboplastin time
Keywords: AGA; Appropriate for Gestational Age; APGAR; Appearance Pulse Grimace Activity Respiration; ARV; Anti-retrovirals; HIV; Human Immunodeficiency Virus; INR; International Normalized Ratio; IU; International Units; NHIS; National Health Insurance Scheme; PCV
Keywords: APTT; activated partial thromboplastin time; EA; extraanalytical; EQA; external quality assurance; GP; general practitioner; IC; interpretive commenting; LDL-C; low-density lipoprotein cholesterol; uAPTT; unexpectedly detected prolonged activated partial
Keywords: ESR; erythrocyte sedimentation rate; AST; aspartate aminotransferase; CK; creatine kinase; CK-MB; creatine-kinase MB; LIS; laboratory information system; COE; computerized order entry; IT; information technology; ED; emergency department; ALT; alanine ami
Keywords: PAD; Peripheral Arterial Disease; CTO; Chronic Total Occlusion; SFA; Superficial Femoral Artery; FP; Femoro-popliteal; IL; Intraluminal; SI; Subintimal; TASC; Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease; AP
Keywords: HBV; hepatitis B virus; PT; prothrombin time; APTT; activated partial thromboplastin time; Hb; hemoglobin; PLT; platelets; CRA; clinical research associates; QC; quality control; IQR; interquartile ranges; INR; international normalized ratio; HCV; hepatit
Keywords: ACT; activated clotting time; aPTT; activated partial thromboplastin time; CT; clot time; EXTEM; extrinsically activated tests of ROTEM assays activated with tissue factor; FFP; fresh frozen plasma; FIBTEM; extrinsically activated tests of ROTEM assays ac
Keywords: APC; advanced pancreatic cancer; aPTT; activated partial thromboplastin time; CA 19-9; carbohydrate antigen 19-9; HR; hazard ratio; KPS; Karnofsky performance status; LMWH; low molecular weight heparin; OS; overall survival; PC; pancreatic cancer; QoL; qu
Keywords: APTT; activated partial thromboplastin time; C; Celcius; CI; confidence intervals; ETP; endogenous thrombin potential; ICU; Intensive Care Unit; INR; international normalised ratio; IQR; inter quartile range; ROSC; return of spontaneous circulation; SAPSI
Anthocyanin supplementation in alleviating thrombogenesis in overweight and obese population: A randomized, double-blind, placebo-controlled study
Keywords: ACN/s; anthocyanin/s; APTT; activated partial thromboplastin time; ADP; adenosine diphosphate; PE-Cy7; allophycocyanin-cyanine 7; APC; allophycocyanin; ANOVA; analysis of variance; BMI; body mass index; CVD; cardiovascular disease; COX-1; cyclooxygenase-1
Keywords: Heparin induced thrombocytopenia; HIT; diagnosis; laboratory testing; clinical identification; 4Ts; 4Â T score; APTT; activated partial thromboplastin time; AUC; area under the curve; CPB; cardiopulmonary bypass; ELISA; enzyme linked immunosorbent assay;
Keywords: L-alanine; Formic acid; Succinic acid; Glutamic acid; glycine; Inosine 5â²-monophosphate; Rat; Genotoxicity; Subchronic toxicity; Safety; 2-AA; 2-aminoanthracene; 9-AA; 9-aminoacridine; A/G; albumin/globulin; APTT; activated partial thromboplastin time;
Keywords: antithrombotic therapy; deep venous thrombosis; direct oral anticoagulants; laboratory; pulmonary embolism; AF; atrial fibrillation; APTT; activated partial thromboplastin time; CHEST; American College of Chest Physicians; DOAC; direct oral anticoagulant;
Keywords: Coagulation; APTT; Surgery; Obstetrics; Gynecology;
Keywords: aPTT; activated partial thromboplastin time; AT; antithrombin; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; F1Â +Â 2; prothrombin fragments F1Â +Â 2; FII; prothrombin; FVIII:C; factor VIII coagulant activity; IDDM; insulin-
Keywords: APS; antiphospholipid syndrome; aPTT; activated partial thromboplastin time; BM; balloon maceration; CVC; central venous catheter; CVST; cerebral venous sinus thrombosis; DVST; Dural venous sinus thrombosis; ET; endovascular treatment; GC; guiding cathete
Keywords: ALT; alanine aminotransferase; aPTT; activated partial thromboplastin time; AST; aspartate aminotransferase; BDL; bile duct ligation; F; factor; IL-6; interleukin 6; LysM; lysozyme; MP; microparticle; PT; prothrombin time; TAT; thrombin-antithrombin compl
Keywords: PVT; portal vein thrombosis; vWf; Villebrand factor; LPS; bacterial lipopolysaccharides; INR; international normalized ratio; CRP; c-reactive protein; APTT; activated partial thromboplastin time;
Keywords: NOAC; novel oral anticoagulant; VKA; vitamin K antagonist; AF; atrial fibrillation; VTE; venous thromboembolism; aPTT; activated partial thromboplastin time; LMWH; low-molecular weight heparin; Cmax; peak concentration; Tmax; time of peak concentration; A
Keywords: AASLD; Association for the Study of Liver Disease; ACLF; acute-on-chronic liver failure; AICF; accelerated intravascular coagulation and fibrinolysis; ALF; acute liver failure; aPTT; activated partial thromboplastin time; CLD; chronic liver disease; DDAVP
Keywords: MNPs; Magnetic nanoparticles; MRI; Magnetic resonance imaging; HAP; Hydroxyapatite; hDMECs; Human Dermal Microvascular Endothelial Cells; APTT; Activated Partial Thromboplastin Time; PT; Prothrombin Time; TCPS; Tissue Culture Polystyrene; Biomaterial; Nan
Keywords: anticoagulant agents; antithrombin agents; argatroban; bivalirudin; cardiopulmonary bypass; platelets; ACCP; American College of Chest Physicians; ACT; activated clotting time; aPTT; activated partial thromboplastin time; CPB; cardiopulmonary bypass; DTI;
Keywords: UFH; unfractionated heparin; LMWH; low-molecular weight heparins; rFXa; recombinant factor Xa; HBC; heparin-binding copolymer; PEG; poly(ethylene glycol); PMAPTAC; poly(3-(methacryloylamino)propyl trimethylammonium chloride); MAPTAC; 3-(methacryloylami
Keywords: aPTT; Activated partial thromboplastin time; AT; Antithrombin; ATC; Antithrombin concentrate; TCH; Texas Children's Hospital; UFH; Unfractionated heparin;
Keywords: PT; prothrombin time; APTT; activated partial thromboplastin time; TF; tissue factor; HIV; human immunodeficiency virus; Vi; initial rate of clot growth; Vst; stationary rate of clot growth; PPP; platelet-poor plasma; SD; standard deviation; a.u; arbitrar
Keywords: PT; prothrombin time; APTT; activated partial thromboplastin time; CAT; calibrated automated thrombography; PL; phospholipid; TCal; thrombin calibrator; PPP; platelet poor plasma; TG; thrombin generation; ETP; endogenous thrombin potential; CV; coefficien
Keywords: RPON; recurrent painless ophthalmoplegic neuropathy; VAS; visual analog scale; MRI; magnetic resonance imaging; NSAI; non-steroidal anti-inflammatory; PTZ-INR; partial thrombin time-International normalized ratio; aPTT; activated partial thrombin time
Keywords: APACHE II; Acute Physiology and Chronic Health Evaluation II; aPTT; activated partial thromboplastin time; ARDS; acute respiratory distress syndrome; ECMO; extracorporeal membrane oxygenation; Fdo2; fraction of delivered oxygen; Fio2; fraction of inspired
Keywords: 2K-1C; two-kidney one-clip; ACE-Is; angiotensin converting enzyme inhibitors; AL; aliskiren; Ang II; angiotensin II; ANP; atrial natriuretic peptide; APTT; activated partial thromboplastin time; ARBs; AT1 receptor antagonists; ASA; aspirin; Fg; fibrinogen